MedTrace Logo

Continuous Glucose Monitoring in Type 2 Diabetes Mellitus

NCT01083043 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2019-02-06

No results posted yet for this study

Summary

It is well known that lowering average blood glucose decreases the risk of diabetic complications involving the small vessels, such as those found in the eyes, nerves and kidney. It is less clear however, if controlling fluctuations in blood glucose will further help to prevent such complications.

The purpose of this study is to examine the relationship between extreme fluctuations in glucose and damage to the blood vessel lining.

Conditions

  • Diabetic Vascular Complications

Sponsors & Collaborators

Principal Investigators

  • Lawrence E Shapiro, MD · Winthrop University Hospital

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01083043 on ClinicalTrials.gov